Yaky Yanay is the founder of Pluristem Therapeutics. He was appointed CEO following the completion of a transition period from a co-CEO structure in June 2019.
Yaky Yanay is the President and CEO of Pluristem Therapeutics (now Pluri Inc.), an Israeli clinical-stage regenerative medicine company developing placental cell therapies using a proprietary 3D manufacturing platform. He was appointed CEO following the completion of a transition period from a co-CEO structure in June 2019. The company focuses on treatments for conditions including ischemia, muscle injury, inflammation, hematological disorders, and radiation exposure.
Full founder directory · Investor directory · Company funding database · Fundraising library